Ibl GmbH

Ibl GmbH — FDA 510(k) Submissions

Ibl GmbH has submitted 6 FDA 510(k) premarket notifications since 2003, of which 6 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Chromatographic/fluorometric Method, Catecholamines, Complement C1q, Antigen, Antiserum, Control, Complement C3, Antigen, Antiserum, Control, Calibrator, Secondary, Radioimmunoassay, Progesterone . Use the specialty filter in the sidebar to narrow results.